Browse

The alkaloid Berberine inhibits the growth of Anoikis-resistant MCF-7 and MDA-MB-231 breast cancer cell lines by inducing cell cycle arrest

DC Field Value Language
dc.contributor.authorKim, J. B.-
dc.contributor.authorYu, J. -H.-
dc.contributor.authorKo, E.-
dc.contributor.authorLee, K. -W.-
dc.contributor.authorPark, S. Y.-
dc.contributor.authorHan, W.-
dc.contributor.authorNoh, D. Y.-
dc.contributor.authorShin, I.-
dc.contributor.authorSong, A. K.-
dc.date.accessioned2012-06-29T08:23:11Z-
dc.date.available2012-06-29T08:23:11Z-
dc.date.issued2010-05-
dc.identifier.citationPHYTOMEDICINE; Vol.17 6; 436-440ko_KR
dc.identifier.issn0944-7113-
dc.identifier.urihttp://hdl.handle.net/10371/77986-
dc.description.abstractBerberine is a pure phenanthren alkaloid isolated from the roots and bark of herbal plants such as Berberis, Hydrastis canadensis and Coptis chinensis Berberine has been established to inhibit the growth of breast cancer cells, but its effects on the drug resistance and anoikis-resistance of breast cancer cells have yet to be elucidated. Anoikis, or detachment-induced apoptosis, may prevent cancer progression and metastasis by blocking signals necessary for survival of localized cancer cells Resistance to anoikis is regarded as a prerequisite for metastasis, however, little is known about the role of berberine in anoikis-resistance We established anoikis-resistant cells from the breast cancer cell lines MCF-7 and MDA-MB-231 by culturing them on a Poly-Hem substratum We then investigated the effects of berberine on the growth of these cells The anoikis-resistant cells had a reduced growth rate and were more invasive than their respective adherent cell lines. The effect of berberine on growth was compared to that of doxorubicine, which is a drug commonly used to treat breast cancer, in both the adherent and anoikis-resistant cell lines. Berberine promoted the growth inhibition of anoikis-resistant cells to a greater extent than doxorubicine treatment Treatment with berberine-induced cell cycle arrest at G0/G1 in the anoikis-resistant MCF-7 and MDA-MB-231 cells as compared to untreated control cells. In summary, these results revealed that berberine can efficiently inhibit growth by inducing cell cycle arrest in anoikis-resistant MCF-7 and MDA-MB-231 cells Further analysis of these phenotypes is essential for understanding the effect of berberine on anoikis-resistant breast cancer cells, which would be relevant for the therapeutic targeting of breast cancer metastasis (C) 2009 Elsevier GmbH All rights reserved.ko_KR
dc.description.sponsorshipThis studywassupportedbyagrantfromtheKoreaHealth
21R&DProject,MinistryofHealth&Welfare,R.O.K(01-PJ3-PG6-
01GN07-0004andA050558).
ko_KR
dc.language.isoenko_KR
dc.publisherELSEVIER GMBH, URBAN & FISCHER VERLAGko_KR
dc.subjectBerberineko_KR
dc.subjectCell cycle arrestko_KR
dc.subjectHerbal plantsko_KR
dc.subjectAnoikis-resistanceko_KR
dc.subjectBreast cancerko_KR
dc.titleThe alkaloid Berberine inhibits the growth of Anoikis-resistant MCF-7 and MDA-MB-231 breast cancer cell lines by inducing cell cycle arrestko_KR
dc.typeArticleko_KR
dc.identifier.doi10.1016/j.phymed.2009.08.012-
dc.citation.journaltitlePHYTOMEDICINE-
dc.description.citedreferenceHO YT, 2009, PHYTOMEDICINE-
dc.description.citedreferenceKim S, 2008, MOLECULES, V13, P2975, DOI 10.3390/molecules13122975-
dc.description.citedreferenceKim JB, 2008, PLANTA MED, V74, P1693, DOI 10.1055/s-0028-1088313-
dc.description.citedreferenceBin Kim J, 2008, PLANTA MED, V74, P39, DOI 10.1055/s-2007-993779-
dc.description.citedreferencePeng PL, 2006, TOXICOL APPL PHARM, V214, P8, DOI 10.1016/j.taap.2005.11.010-
dc.description.citedreferenceMantena SK, 2006, MOL CANCER THER, V5, P296, DOI 10.1158/1535-7163.MCT-05-0448-
dc.description.citedreferenceLetasiova S, 2006, J PHARM PHARMACOL, V58, P263, DOI 10.1211/jpp.58.2.0015-
dc.description.citedreferenceSheridan C, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1610-
dc.description.citedreferenceLin JP, 2006, WORLD J GASTROENTERO, V12, P21-
dc.description.citedreferenceGilmore AP, 2005, CELL DEATH DIFFER, V12, P1473, DOI 10.1038/sj.cdd.4401723-
dc.description.citedreferenceCollins NL, 2005, MOL CELL BIOL, V25, P5282, DOI 10.1128/MCB.25.12.5282-5291.2005-
dc.description.citedreferenceShen XD, 2004, AM J PATHOL, V165, P1315-
dc.description.citedreferenceMonteiro HP, 2004, NITRIC OXIDE-BIOL CH, V10, P1, DOI 10.1016/j.niox.2004.02.002-
dc.description.citedreferenceDiaz-Montero CM, 2003, EUR J CANCER, V39, P2395, DOI 10.1016/S0959-8049(03)00575-5-
dc.description.citedreferenceJantova S, 2003, J PHARM PHARMACOL, V55, P1143, DOI 10.1211/0022357021422-
dc.description.citedreferenceMarco RAW, 2003, J CELL BIOCHEM, V88, P1038, DOI 10.1002/jcb.10465-
dc.description.citedreferenceSchmidt M, 2002, BRIT J CANCER, V87, P924, DOI 10.1038/sj.bjc.6600566-
dc.description.citedreferenceFiucci G, 2002, ONCOGENE, V21, P2365, DOI 10.1038/sj/onc/1205300-
dc.description.citedreferenceFrisch SM, 2001, CURR OPIN CELL BIOL, V13, P555-
dc.description.citedreferenceZhu ZY, 2001, CANCER RES, V61, P1707-
dc.description.citedreferencePlath T, 2000, J CELL BIOL, V150, P1467-
dc.description.citedreferenceLin JG, 1999, AM J CHINESE MED, V27, P265-
dc.description.citedreferenceCHEN KT, 1994, CHINESE MED J-PEKING, V107, P808-
dc.description.tc9-
Appears in Collections:
College of Medicine/School of Medicine (의과대학/대학원)Surgery (외과학전공)Journal Papers (저널논문_외과학전공)
Files in This Item:
There are no files associated with this item.
  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse